CINGAL works by combining Anika’s proprietary cross-linked hyaluronic acid formulation (MONOVISC) with a well-established FDA approved steroid (Triamcinolone Hexacetonide).

  • The first and only hyaluronic acid plus corticosteroid combination CE approved therapy for the pain of OA


  • Single-injection treatment


  • Proven effects through 6 months while steroid provides fast short-term pain relief within days of injection


  • Highly concentrated, non-animal based HA


  • Strong safety profile in both an initial injection as well as a repeat injection


  • Indicated for the treatment of pain in osteoarthritis (OA) of the knee in patients who have failed to respond adequately to conservative non-pharmacologic therapy and to simple analgesics (e.g. acetaminophen)


  • For additional information please visit Anika Therapeutics’ website about CINGAL: